Schizophrenia Clinical Trials
Recruiting schizophrenia studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat schizophrenia. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting schizophrenia studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting schizophrenia trials
Developing a Virtual Reality-assisted Intervention for Emotion Regulation Difficulties in Psychosis
Improving Quality of Informal Care for People With Schizophrenia
Frontal Gamma Coherence Neurofeedback for Patients With Schizophrenia
LIFU Effects & Outcomes: Mechanisms Evaluating Striatal Systems Imaging (LEO MESSI)
Shared Decision Making for Antipsychotic Medications
Brain Network Mechanisms of Cognitive Impairments in Major Psychiatric Disorders and Their Clinical Applications
Mobile Thinking Intervention: A Inital Test
Feasibility and Acceptability of Mobile Mental Health App for SZ and SZA
Longitudinal PET Imaging of Antipsychotic Binding to the Dopamine-3 Receptor in Schizophrenia
Digital Implementation Support to Achieve Uptake and Integration of Task-Shared Care for Schizophrenia in Primary Care in India
Optimizing CBSST With Executive Function Training for Schizophrenia (R33)
Xingqi Daozhi Decoction for Antipsychotic-Induced Constipation
Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 3)
NEURO-COGS: Neurometabolic Mechanisms of Cognitive Training in Schizophrenia
Stratification and Treatment in Early Psychosis Study - ENHANCE
Overnight Thalamic TES-TI to Modulate Sleep Spindles in Individuals With Schizophrenia Spectrum Disorders and Matched Healthy Controls
Comparison of Accelerated Intermittent Theta Burst Stimulation vs High Frequency Transcranial Magnetic Stimulation (Hf-rTMS) on Cognitivesymptoms in Treatment-resistant Schizophrenia
Group DBT Skills Training for First Episode Psychosis
Effectiveness of a Board Game Intervention on Cognitive and Functional Outcomes in Older Adults With Schizophrenia
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
Clinical Trial of an IL-23 Inhibitor for Immune Activation in Clinical Trial of an IL-23 Inhibitor for Immune Activation in People With Schizophrenia
The Effect of Combined Brain Stimulation and Exercise for Improving Cognitive Function in Schizophrenia
The Purpose of the Study is to Evaluate the Safety and Effectiveness of dTMS for Reducing Antipsychotic-induced Weight Gain
Online Intervention To Improve Motivation
Exploring the Genetics of Schizophrenia in Manitoba
A Study to Investigate Pharmacokinetics, Safety, and Tolerability of B2227 Extended-Release Injectable Suspension and Vraylar® in Participants With Schizophrenia
A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Brexpiprazole for Extended-Release Injection in Subjects With Schizophrenia
Developing a Recovery-Oriented Suicide Prevention Program for Young People at Clinical High Risk for Psychosis
REACH Study (Recovery Environments: Assessing Cognitive & Brain Health in Community Mental Health)
Enhancing Veteran-Clinical Collaboration in VA PRRCs
Pilot Study of Sensor-Informed Smartphone-based Mental Health Interventions for Mood in Early Psychosis
Prucalopride for Cognitive Functioning in Schizophrenia
Evaluate Pharmacokinetics, Safety, and Tolerability of AX251 LAI in Patients With Schizophrenia
Evaluating Safety and Efficacy of VV119 in Acute Schizophrenia Adults
Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
Cognitive Strategies in Early Psychosis 2
Treatment Resistance in Psychiatric Disorders: the Search for Biological Markers Predictive of Response to Treatment
Digital Therapeutics for Social Cognitive Function in Schizophrenia Spectrum Disorder
tACS for Working Memory in Schizophrenia
Eye-Movement Intervention for Cognitive Impairment Across Schizophrenia Spectrum
MicroRNAs as Biomarkers in First Episode Schizophrenia
Stratification and Treatment in Early Psychosis Study -ASSIST
The Effect of Comorbid Alcohol/Substance Use
Transcranial Sonography and Machine Learning for Schizophrenia Identification
Investigation of the Effects of Angling as Supportive Therapy in Schizophrenia Treatment on Serum Parameters, Anxiety, Depression, and Quality of Life
Multimodal Intervention to Support Hospital-to-Community Transition in Bipolar Disorder
Impact of Cannabis Consumption on Psychotic Symptoms and Reality Monitoring in Patients With Schizophrenia: a Real-life Study
Emotional Eating, Sleep Quality, Mental State and Metabolic Syndrome
A 20-Year Follow-up of First Episode Psychosis: Longitudinal Effects of Early Treatment Strategies and Relapse
A Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of KR23248 Capsules in Healthy Adult Subjects
The Mouth Matters in Mental Health Trial -2
52-week Open Label Safety-Tolerability Study
Venous Tourniquet vs. Arterial Tourniquet for Seizure Monitoring in ECT
Effects of Gamified Rehabilitation on Cognitive and Psychosocial Outcomes in Inpatients With Schizophrenia
The Effect of Game-Based Intervention on the Cognition of Schizophrenia Patients
A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively
Steady-state Bioequivalence Study of Aripiprazole for Injection in Patients With Schizophrenia.
A Phase 2 Study to Evaluate the Efficacy and Safety of LY03020 in Acutely Psychotic Participants With Schizophrenia
New trials in Little Rock, AR?
Pick a condition and we'll email you once a week when a new study starts recruiting in Little Rock, AR. Unsubscribe anytime.
Schizophrenia clinical trials — common questions
Are schizophrenia clinical trials free to join?
Yes. Participating in a schizophrenia clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a schizophrenia clinical trial?
Each schizophrenia study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a schizophrenia trial near me?
Use the location controls above. We'll show recruiting schizophrenia trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many schizophrenia trials are recruiting right now?
We're currently tracking roughly 120 recruiting schizophrenia trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.